genedrive plc (AIM:GDR)

Market Cap	9.01M
Revenue (ttm)	954.00K
Net Income (ttm)	-5.23M
Shares Out	1.03B
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,854,610
Average Volume	7,080,231
Open	0.8400
Previous Close	0.8000
Day's Range	0.7951 - 0.9000
52-Week Range	0.1900 - 2.5500
Beta	0.96
RSI	49.68
Earnings Date	Dec 31, 2025

About genedrive

genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The company provides Genedrive system, rapid nucleic acid thermocycler and fluorescence signal detection system for target discrimination used for qualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a certified test for identification of individuals unlikely to respond to the commonly prescribed antiplatelet...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 43
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: GDR

Financial Performance

In 2025, genedrive's revenue was 954,000, an increase of 90.42% compared to the previous year's 501,000. Losses were -5.23 million, -26.06% less than in 2024.